Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases: A Prospective Comparative Pilot Study

NCT07348588 is registered in ClinicalTrials.gov with Centro de Pesquisa Rubens Siqueira as lead sponsor.

NCT NCT07348588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07348588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases: A Prospective Comparative Pilot Study
Lead sponsor
Centro de Pesquisa Rubens Siqueira
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
July 10, 2025
Completion date
December 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensive macular atrophy with pseudodrusen (emap), retinitis pigmentosa (rp)